| Defibrotide Prophylaxis of Transplant Associated-Thrombotic Microangiopathy for Neuroblastoma (NCT06182410) | University of California, San Francisco | 2024-08-01 |
| Sacituzumab Govitecan With or Without Atezolizumab Immunotherapy in Rare Genitourinary Tumors (SMART) Such as High Grade Neuroendocrine Carcinomas, Adenocarcinoma, and Squamous Cell Bladder/Urinary Tract Cancer, Renal Medullary Carcinoma and Penile C... (NCT06161532) | National Cancer Institute (NCI) | 2024-08-01 |
| Study of RP2 in Combination With Second-line Therapy in Patients With Locally Advanced or Metastatic HCC (NCT05733598) | Replimune, Inc. | 2024-08-01 |
| The Effect of Increasing Dialysate Calcium on T50 in Subjects With Secondary Hyperparathyroidism and ESKD (NCT06398002) | Iain Bressendorff | 2024-08-01 |
| MB-dNPM1-TCR.1 in Relapsed/Refractory AML (NCT06424340) | Miltenyi Biomedicine GmbH | 2024-08-01 |
| Connectomic Targeted TMS Target for Refractory Anxiety (NCT06376877) | Brigham and Women's Hospital | 2024-08-01 |
| Establishing Best Treatment Strategy for T4 Esophageal Cancer (NCT06531434) | National Cheng-Kung University Hospital | 2024-08-01 |
| Efficacy and Safety of Dalpiciclib Plus Toremifene in the Treatment of Advanced First-line HR Positive and HER2 Negative Breast Cancer: a Multicenter, Single Arm, Exploratory Phase II Clinical Study (NCT06495515) | Tianjin Medical University Cancer Institute and Hospital | 2024-08-01 |
| Neoadjuvant/Adjuvant Cadonilimab Plus Chemotherapy in Patients With Resectable PD-L1 Negative NSCLC (NCT06532591) | Sichuan Cancer Hospital and Research Institute | 2024-08-01 |
| Sacituzumab Govitecan for Advanced Esophageal Squamous Cell Carcinoma (NCT06329869) | National Taiwan University Hospital | 2024-08-01 |
| Evaluation of Efficacy of Botulinum Toxin A Plus Oral Tadalafil 5 mg in Diabetic Men With Erectile Dysfunction (NCT06583590) | Aswan University Hospital | 2024-08-01 |
| Baricitinib for the Lung Injury Following Spontaneous SAH (NCT06439615) | Tang-Du Hospital | 2024-08-01 |
| Analyse of Diagnosis Value of Keloid on 68Ga-RGD PET-CT (NCT07660406) | Peking Union Medical College Hospital | 2024-08-01 |
| A Phase II Study to Evaluate the Efficacy and Safety of of DR10624 in Subjects With Severe Hypertriglyceridemia (NCT06555640) | Zhejiang Doer Biologics Co., Ltd. | 2024-08-01 |
| Tislelizumab and Induction Chemotherapy for Larynx Preservation in Resectable Advanced Laryngeal/Hypopharyngeal Cancer (NCT06554028) | Henan Cancer Hospital | 2024-08-01 |
| The Safety and Efficacy of Rapamycin on Communicating Hydrocephalus Secondary to Intraventricular Hemorrhage (NCT06563817) | Beijing Tiantan Hospital | 2024-08-01 |
| The Effect of Rituximab on Cognitive and Hand Functions in Secondary Progressive Multiple Sclerosis (NCT06599307) | Cairo University | 2024-08-01 |
| Pimavanserin and Aggression and Social Cognition. (NCT05895513) | Ohio State University | 2024-08-01 |
| Testing the Use of AMG 510 (Sotorasib) and Panitumumab as a Targeted Treatment for KRAS G12C Mutant Solid Tumor Cancers (A ComboMATCH Treatment Trial) (NCT05638295) | National Cancer Institute (NCI) | 2024-08-01 |
| Effect of Pectin in Chronic Kidney Disease Patients ( Stage 3 and 4 ) (NCT06531993) | Assiut University | 2024-08-01 |
| MEK Inhibitors for the Treatment of Hypertrophic Cardiomyopathy in Patients With RASopathies (NCT06555237) | Medical University of Warsaw | 2024-08-01 |
| Investigation Into the Use of BAH243 Lentiviral Vector for Gene Therapy in Treating Sickle Cell Disease (NCT06399107) | Essen Biotech | 2024-08-01 |
| Danazol for Treatment of Cytopenias in Patients With Cirrhosis (NCT04873102) | University of Southern California | 2024-08-01 |
| Pucotenlimab Plus Radiotherapy and Chemotherapy for Neoadjuvant Treatment of Locally Advanced Rectal Cance(PUCRT) (NCT06770270) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2024-08-01 |
| Pharmacist-led Intervention for Injectable HIV Treatment for Women With Health-related Social Needs (NCT06411223) | Yale University | 2024-08-01 |
| Clinical Study of Trop2 CAR-NK in the Treatment of Relapsed/Refractory Non-Small Cell Lung Cancer (NSCLC) (NCT06454890) | Henan Cancer Hospital | 2024-08-01 |
| Repurposing Empagliflozin and Dapagliflozin for Paediatric Heart Failure: Translational Approach and Dose Rationale (NCT06012266) | Centre Hospitalier Universitaire Vaudois | 2024-08-01 |
| Tislelizumab Combined With Chemotherapy and Thoracic Radiotherapy in ES-SCLC (NCT06536868) | Second Hospital of Shanxi Medical University | 2024-08-01 |
| Sonrotoclax, Zanubrutinib and CD20mab in Untreated MCL Patients (NCT06463691) | Tianjin Medical University Cancer Institute and Hospital | 2024-08-01 |
| SATELLITE Study (feaSibility sAfeTy Efficacy dostarLimab earLy-stage defIcient endomeTrial cancEr) (NCT06278857) | Queensland Centre for Gynaecological Cancer | 2024-08-01 |
| AK117 (Anti-CD47 mAb) Plus Cetuximab or AK104 (Anti-PD-1/CTLA-4 bsAb) as Second-Line Therapy in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (NCT06508606) | West China Hospital | 2024-08-01 |
| A Phase 2 Study Using Aliya PEF Plus Pembro for Sarcoma (NCT06494787) | Sarcoma Oncology Research Center, LLC | 2024-08-01 |
| Phase II Clinical Trial of Chidamide Combined With AK112 for Second-line and Advanced Bone and Soft Tissue Sarcoma (NCT06637007) | Shanxi Province Cancer Hospital | 2024-08-01 |
| RECOVER-SLEEP: Platform Protocol (NCT06404086) | Duke University | 2024-07-31 |
| Study of BB-031 in Acute Ischemic Stroke Patients (RAISE) (NCT06226805) | Basking Biosciences, Inc. | 2024-07-31 |
| Cryoablation Combined With PD-1 Antibody and Bevacizumab for Hepatocellular Carcinoma (NCT06530784) | Shanghai Zhongshan Hospital | 2024-07-31 |
| Rabies mAb CBB 1 Combination Vaccine in Healthy People With Antibody Neutralization Activity and Safety Phase Clinical Trials (NCT06548139) | Changchun BCHT Biotechnology Co. | 2024-07-31 |
| A Study of BL-B01D1 in Combination With Osimertinib Mesylate Tablets in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NCT06498986) | Sichuan Baili Pharmaceutical Co., Ltd. | 2024-07-31 |
| Darxicilib Combined With Abiraterone Acetate Tablets (II) for the Treatment of Advanced Metastatic Castration-resistant Prostate Cancer. (NCT06500247) | Qilu Hospital of Shandong University | 2024-07-31 |
| Evaluation of Fuling Yunhua Granules and Dihuang Baoyuan Granules in Drug Naive Type 2 Diabetes Patients (NCT06575478) | Beijing Supreme Life Pharmaceutical Technology Co., Ltd. | 2024-07-31 |
| RECOVER-SLEEP: Platform Protocol, Appendix_B (CPSD) (NCT06404112) | Duke University | 2024-07-31 |
| The Efficacy and Safety of LM-302 in Combination With Candonilimab and Capecitabine for First-Line Treatment in Patients With Unresectable Advanced, Recurrent, or Metastatic CLDN18.2-Positive Gastric or Gastroesophageal Junction Adenocarcinoma (NCT06587425) | Shanghai Zhongshan Hospital | 2024-07-31 |
| Assessment of the Initial Efficacy and Safety of BRM424 Ophthalmic Solutions in Patients With Neurotrophic Keratitis (NCT05927428) | BRIM Biotechnology Inc. | 2024-07-31 |
| Defactinib, Avutometinib and Nivolumab for the Treatment of Anti-PD1 Refractory LKB1-Mutant Advanced Non-Small Cell Lung Cancer (NCT06495125) | Emory University | 2024-07-31 |
| Phase 2 Study of WGI-0301 for Advanced HCC (NCT06309485) | Zhejiang Haichang Biotech Co., Ltd. | 2024-07-31 |
| Fecal Microbiota Translantation (FMT) to Reduce Inflammation in PLWH: The Gutsy Pilot Study (NCT06022406) | Jean-Pierre Routy | 2024-07-31 |
| Tirofiban for Successful Endovascular Stroke Thrombectomy (NCT06373042) | Zhongming Qiu | 2024-07-31 |
| Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders (NCT06434363) | M.D. Anderson Cancer Center | 2024-07-31 |
| A Phase 2/3 Study to Evaluate the Efficacy and Safety of Tinlarebant in Subjects With Stargardt Disease (NCT06388083) | Belite Bio, Inc | 2024-07-31 |
| A Trial of SHR-A2102 With Adebrelimab With or Without Other Antitumor Therapy in Advanced or Metastatic Non-small Cell Lung Cancer (NCT06512051) | Shanghai Hengrui Pharmaceutical Co., Ltd. | 2024-07-30 |
| Adebrelimab Combined With Albumin Paclitaxel and Nedaplatin as Neoadjuvant Therapy for Locally Advanced Resectable ESCC (NCT06508229) | Harbin Medical University | 2024-07-30 |
| Fluorescence Image Guided Surgery Followed by Intraoperative Photodynamic Therapy for Improving Local Tumor Control in Patients With Locally Advanced or Recurrent Colorectal Cancer (NCT06307548) | Roswell Park Cancer Institute | 2024-07-30 |
| Randomized Study of Neo-adjuvant and Adjuvant Pembrolizumab With and Without Targeted Blood Brain Barrier Opening Using Exablate MRI-guided Focused Ultrasound (Exablate MRgFUS) for Recurrent Glioblastoma (NCT05879120) | M.D. Anderson Cancer Center | 2024-07-30 |
| Sustainable and Efficient Platform Trial of New Therapeutic Development for Early Breast Cancer (NCT06535893) | Nagoya City University | 2024-07-30 |
| A Trial to Assess Efficacy, Safety, Pharmacokinetics of Octreotide Subcutaneous Injection in Patients With Gastroentero-pancreatic Neuroendocrine Tumor (GEP-NET) (NCT06505395) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2024-07-30 |
| A Clinical Study of B007 in the Treatment of Primary Membranous Nephropathy. (NCT06470191) | Shanghai Jiaolian Drug Research and Development Co., Ltd | 2024-07-30 |
| A Study to Learn About How a New Pneumococcal Vaccine Works in Children (NCT06531538) | Pfizer | 2024-07-30 |
| Donafenib Combine With Sintilimab and HAIC in Neoadjuvant of Resectable Hepatocellular Carcinoma (NCT06512467) | Tianjin Medical University Cancer Institute and Hospital | 2024-07-30 |
| Evaluation of the Efficacy of Local Budesonide Treatment in Children with Crohn's Disease Located in the Esophagus And/or Stomach And/or Duodenum (NCT06719622) | Medical University of Warsaw | 2024-07-30 |
| Long-term Safety and Tolerability of BHV-7000 (NCT06443463) | Biohaven Therapeutics Ltd. | 2024-07-30 |
| Efficacy of Cognitive Behavioral Therapy for Insomnia to Treat Insomnia Symptoms in Individuals With Multiple Sclerosis (NCT06428006) | University of Kansas Medical Center | 2024-07-30 |
| Combination of Equisetum Arvense and Palmitoylethanolamide (PEA) for the Management of Patients With Chronic Pain in a Before-after Study (NCT07110480) | noiVita Srls | 2024-07-29 |
| Selpercatinib Pre-RAI in Patients With RET Fusion Thyroid Cancer (RAISE) (NCT06458036) | Children's Hospital of Philadelphia | 2024-07-29 |
| A Study of XS-02 Capsules in Patients With Advanced Solid Tumors (NCT06531486) | NovaOnco Therapeutics Co., Ltd. | 2024-07-29 |
| Study of SPG302 in Adult Participants With Mild-to-Moderate Alzheimer's Disease (AD) (NCT06427668) | Spinogenix | 2024-07-29 |
| ATRA and Carfilzomib in Plasma Cell Myeloma Patients (NCT06536413) | The Methodist Hospital Research Institute | 2024-07-29 |
| A Study of Ocular Toxicity Evaluation and Mitigation During Treatment With Mirvetuximab Soravtansine in Participants With Recurrent Ovarian Cancer With High Folate Receptor-Alpha Expression (NCT06365853) | AbbVie | 2024-07-29 |
| Alternate Dosing Study of MK-6024 in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) (MK-6024-016) (NCT06482112) | Merck Sharp & Dohme LLC | 2024-07-29 |
| Efficacy and Safety of Early Initiation of Butylphthalide Treatment in Patients With Acute Ischemic Stroke. (NCT06472921) | Xiangya Hospital of Central South University | 2024-07-29 |
| Comparison of VA (Venetoclax, Azacitidine), VACl (VA, Cladribine), VACh (VA, Chidamide), and Alternating VACl/VACh in Newly Diagnosed Acute Myeloid Leukemia (NCT06532552) | The First Affiliated Hospital of Soochow University | 2024-07-29 |
| A Study of IBI3003 in Subjects With Relapsed or Refractory Multiple Myeloma (NCT06083207) | Innovent Biologics (Suzhou) Co. Ltd. | 2024-07-29 |
| Deucravacitinib (BMS-986165) for Pityriasis Rubra Pilaris (NCT06444399) | Mayo Clinic | 2024-07-29 |
| Empagliflozin on Residual Kidney Function in Incident Peritoneal Dialysis Patients (NCT06483074) | Chinese University of Hong Kong | 2024-07-29 |
| A Phase II Study of SSGJ-707 Combination Therapy in Advanced NSCLC Patients (NCT06412471) | Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. | 2024-07-26 |
| A Clinical Study of 9MW2821 (and PD-1 Inhibitor) in Locally Advanced or Metastatic Triple-Negative Breast Cancer (NCT06492005) | Mabwell (Shanghai) Bioscience Co., Ltd. | 2024-07-26 |
| Clinical Investigation to Assess the Efficacy of Manual Toothbrushes in the Reduction of Plaque and Gingivitis. (NCT06565897) | Colgate Palmolive | 2024-07-26 |
| Longitudinal Outpatient Treatment for Cannabis Use Disorder (NCT06107062) | University of Colorado, Boulder | 2024-07-26 |
| A Study to Evaluate Solriktug in Adult Participants With Asthma (NCT06496607) | Uniquity One (UNI) | 2024-07-26 |
| Emergency Stroke Unit for Acute Cerebrovascular Events ( ESU-ACE-A ) (NCT06492239) | Beijing Tiantan Hospital | 2024-07-26 |
| A Phase 2 Clinical Trial to Evaluate Efficacy, Safety, and Tolerability of Navepegritide in Combination With Lonapegsomatropin in Children With Achondroplasia (NCT06433557) | Ascendis Pharma Growth Disorders A/S | 2024-07-26 |
| A Study of GR1014 Cutaneous Gel for the Prevention of Skin Reactions Caused by Radiation Therapy for Breast Cancer (NCT07192588) | Graegis Pharmaceuticals Ltd | 2024-07-26 |
| Zanubrutinib in Primary Cold Agglutinin Disease (NCT06067048) | Stichting Hemato-Oncologie voor Volwassenen Nederland | 2024-07-26 |
| Tislelizumab in People With Colorectal Cancer (NCT06529523) | Memorial Sloan Kettering Cancer Center | 2024-07-26 |
| A Study to Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Narcolepsy Type 2 (NCT06555783) | Alkermes, Inc. | 2024-07-26 |
| GU-01: Glycyrrhizin in Prostate Cancer (NCT06378346) | University of Illinois at Chicago | 2024-07-25 |
| A Prospective Study of MSS-type Metastatic Colorectal Cancer Receiving Multiple Lines of Standard Chemotherapy, Bevacizumab Combined With Adebrelimab (NCT06513221) | Fudan University | 2024-07-25 |
| A Study to Learn About How a New Pneumococcal Vaccine Works in Infants (NCT06524414) | Pfizer | 2024-07-25 |
| NAC for Hematopoietic Recovery in SAA (NCT06518044) | Peking University People's Hospital | 2024-07-25 |
| Evaluation of a Targeted Magnetic Resonance Imaging Contrast Agent in Prostate Cancer Patients (NCT06262139) | Songqi Gao | 2024-07-25 |
| Eliminating Breast Surgery for Breast Cancer Patients With Clinical Complete Response to Neoadjuvant Systemic Therapy (NCT06498154) | Tianjin Medical University Cancer Institute and Hospital | 2024-07-25 |
| Iron Administration Via Colonic TET Combined With WMT for ID (NCT06487299) | The Second Hospital of Nanjing Medical University | 2024-07-25 |
| Topical Ruxolitinib Evaluation in Immune-related Vitiligo-like Depigmentation (NCT07725432) | University of Zurich | 2024-07-25 |
| Assessing Antiviral Treatments in Early Symptomatic RSV (NCT06488300) | University of Oxford | 2024-07-25 |
| Intrahepatic and Peripheral Responses to Imdusiran (AB-729) in Chronic Hepatitis B (NCT06154278) | University of Maryland, Baltimore | 2024-07-25 |
| Orexin Receptor Antagonism and Sleep in Stimulant Use Disorder (NCT06444256) | The University of Texas Health Science Center, Houston | 2024-07-25 |
| Phase 2 Open-label Extension Study of AOC 1020 in Participants With Facioscapulohumeral Muscular Dystrophy (FSHD) (NCT06547216) | Avidity Biosciences, Inc. | 2024-07-25 |
| Novel Magnetic Resonance Imaging-Guided Ultrasound-Stimulated Microbubble Radiation Treatment for Patients With Chest-Wall and Breast Cancer (NCT06185972) | Sunnybrook Health Sciences Centre | 2024-07-25 |
| 4-Week, Multi-center Dose-Ranging Study for the IBS-C in Pts. 6 to <12 Yrs (NCT06553547) | Ardelyx | 2024-07-24 |
| Adebrelimab Combined With Famitinib and Irinotecan in Advanced Gastric Cancer After Failure of First-Line Therapy (NCT07309185) | Shandong Tumor Hospital | 2024-07-24 |
| A Study of MRG006A in the Treatment of Patients With Advanced Solid Tumors (NCT07093970) | Lepu Biopharma Co., Ltd. | 2024-07-24 |